Neonatal abstinence syndrome clinical practice guidelines for Ontario
K Dow, A Ordean, J Murphy-Oikonen, J Pereira… - Journal of Population …, 2012 - jptcp.com
Ontario's clinical practice guidelines for neonatal abstinence syndrome (NAS) provide
evidence-informed recommendations that address the needs of substance using pregnant …
evidence-informed recommendations that address the needs of substance using pregnant …
A cohort comparison of buprenorphine versus methadone treatment for neonatal abstinence syndrome
ES Hall, BT Isemann, SL Wexelblatt… - The Journal of …, 2016 - Elsevier
Objectives To compare the duration of opioid treatment and length of stay among infants
treated for neonatal abstinence syndrome (NAS) by using a pilot buprenorphine vs …
treated for neonatal abstinence syndrome (NAS) by using a pilot buprenorphine vs …
Opioid use in pregnancy, neonatal abstinence syndrome, and childhood outcomes: executive summary of a joint workshop by the Eunice Kennedy Shriver National …
UM Reddy, JM Davis, Z Ren, MF Greene - Obstetrics & …, 2017 - journals.lww.com
In April 2016, the Eunice Kennedy Shriver National Institute of Child Health and Human
Development invited experts to a workshop to address numerous knowledge gaps and to …
Development invited experts to a workshop to address numerous knowledge gaps and to …
Neonatal abstinence syndrome: presentation and treatment considerations
K Kaltenbach, HE Jones - Journal of addiction medicine, 2016 - journals.lww.com
The increase in opioid use among the general population is reflected in pregnant women
and neonatal abstinence syndrome (NAS) statistics. This increase has produced an …
and neonatal abstinence syndrome (NAS) statistics. This increase has produced an …
Comparison of safety and efficacy of methadone vs morphine for treatment of neonatal abstinence syndrome: a randomized clinical trial
JM Davis, J Shenberger, N Terrin, JL Breeze… - JAMA …, 2018 - jamanetwork.com
Importance Although opioids are used to treat neonatal abstinence syndrome (NAS), the
best pharmacologic treatment has not been established. Objective To compare the safety …
best pharmacologic treatment has not been established. Objective To compare the safety …
Neonatal abstinence syndrome severity index predicts 18-month neurodevelopmental outcome in neonates randomized to morphine or methadone
T Flannery, JM Davis, AJ Czynski, LM Dansereau… - The Journal of …, 2020 - Elsevier
Objective To develop an index to determine which opioid-exposed neonates have the most
severe neonatal abstinence syndrome (NAS). Study design Full-term neonates with NAS (n …
severe neonatal abstinence syndrome (NAS). Study design Full-term neonates with NAS (n …